JWA
ARNA

JFS Wealth Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

JFS Wealth Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-74
Closed -$1K – 460
2017
Q1 		$1K Hold
74
– – ﹤0.01% 431
2016
Q4 		$1K Hold
74
– – ﹤0.01% 431
2016
Q3 		$1K Hold
74
– – ﹤0.01% 470
2016
Q2 		$1K Hold
74
– – ﹤0.01% 485
2016
Q1 		$1K Hold
74
– – ﹤0.01% 609
2015
Q4 		$1K Hold
74
– – ﹤0.01% 526
2015
Q3 		$1K Hold
74
– – ﹤0.01% 463
2015
Q2 		$3K Hold
74
– – ﹤0.01% 455
2015
Q1 		$3K Hold
74
– – ﹤0.01% 453
2014
Q4 		$3K Hold
74
– – ﹤0.01% 469
2014
Q3 		$3K Hold
74
– – ﹤0.01% 419
2014
Q2 		$4K Buy
+74
New +$4.66K ﹤0.01% 400

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

JFS Wealth Advisors's ARNA Position: Q2 2017 in Review

JFS Wealth Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2017, closing a stake of 74 shares — an estimated $1K sold.

JFS Wealth Advisors first reported a position in ARNA in Q2 2014 and held it in 12 quarters. The position peaked at $4K in Q2 2014. 102 funds tracked by Wall St. Rank hold ARNA as of Q2 2017.

  • JFS Wealth Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • JFS Wealth Advisors sold 74 Arena Pharmaceuticals Inc shares in Q2 2017, an estimated $1K.
  • JFS Wealth Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2014 and held it in 12 quarters.
  • JFS Wealth Advisors's Arena Pharmaceuticals Inc position peaked at $4K in Q2 2014.
  • 102 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2017.

Based on JFS Wealth Advisors's 13F filing for Q2 2017, filed 28 Jul 2017.